Sulindac Enhances the Proteasome Inhibitor Bortezomib-Mediated Oxidative Stress and Anticancer Activity

Explore this paper's citation graph

Summary

Sulindac synergistically augments the anticancer effects of bortezomib primarily through cooperative ROS generation and oxidative DNA damage, thereby representing a novel combination therapy against colon cancer.

Type
article
Published
2005-07-15
Cited by
66
References
47
Access
Open access

Keywords

Computer science

References

Cited by

Related papers

No related papers recorded.